Non-Clear Cell Renal Cell Carcinoma (nccRCC)

Oncology

Prevalence

48.0 / 100K

Incidence

15.0 / 100K/yr

0 drugs in development·0 companies·2 clinical trials

Frequently asked questions

How many clinical trials target Non-Clear Cell Renal Cell Carcinoma (nccRCC)?

There are 2 clinical trials targeting Non-Clear Cell Renal Cell Carcinoma (nccRCC) tracked by BioSniper.

What is the prevalence of Non-Clear Cell Renal Cell Carcinoma (nccRCC)?

The estimated prevalence of Non-Clear Cell Renal Cell Carcinoma (nccRCC) is approximately 48.0 per 100,000 population.

Deep-dive into Non-Clear Cell Renal Cell Carcinoma (nccRCC)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Non-Clear Cell Renal Cell Carcinoma (nccRCC) — Drugs in Development & Clinical Trials | BioSniper